amodiaquine has been researched along with artesunate in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bathurst, I; Burrows, JN; Charman, SA; Cross, RM; Flanigan, DL; Fronczek, FR; Guida, WC; Kyle, DE; LaCrue, AN; Maignan, JR; Manetsch, R; Monastyrskyi, A; Mutka, TS; Sáenz, FE; Shackleford, DM; White, KL; Wojtas, L | 1 |
| Coelho, L; Lukens, AK; Mazitschek, R; Moreira, R; Nogueira, F; Paulo, A; Santos, SA; Wirth, DF | 1 |
| Agarwal, D; Alifrangis, M; Awasthi, SK; Gupta, RD; Nielsen, MA; Sharma, K; Sharma, M; Singh, AK; Singh, S | 1 |
| Attram, HD; Chibale, K; Wittlin, S | 1 |
| Das, US; Khan, SI; Ponnan, P; Rawat, DS; Taylor, D; Tekwani, BL; Tripathi, M; Velpandian, T | 1 |
| Cheong, SL; Ng, CH; Tibon, NS | 1 |
| Baum, J; Bridgford, JL; Charman, SA; Churchyard, A; Crespo, B; Deni, I; Fidock, DA; Gahalawat, S; Gamo, FJ; Laleu, B; Lawong, A; Mittal, N; Mok, S; Niederstrasser, H; Okombo, J; Palmer, MJ; Phillips, MA; Posner, B; Ready, JM; Striepen, J; Winzeler, E; Wittlin, S; Yeo, T; Zhou, A | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
1 review(s) available for amodiaquine and artesunate
| Article | Year |
|---|---|
Current progress in antimalarial pharmacotherapy and multi-target drug discovery.
Topics: Animals; Antimalarials; Artemisinins; Drug Discovery; Drug Resistance; Humans; Malaria; Molecular Structure; Paclitaxel; Quinolines | 2020 |
7 other study(ies) available for amodiaquine and artesunate
| Article | Year |
|---|---|
Orally bioavailable 6-chloro-7-methoxy-4(1H)-quinolones efficacious against multiple stages of Plasmodium.
Topics: Animals; Antimalarials; Humans; Inhibitory Concentration 50; Malaria; Mice; Microsomes, Liver; Parasitemia; Plasmodium; Plasmodium berghei; Quinolones; Structure-Activity Relationship | 2014 |
Exploring the 3-piperidin-4-yl-1H-indole scaffold as a novel antimalarial chemotype.
Topics: Antimalarials; Cell Survival; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Indoles; Malaria; Molecular Structure; Niacinamide; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship | 2015 |
4-Aminoquinoline derivatives: Synthesis, in vitro and in vivo antiplasmodial activity against chloroquine-resistant parasites.
Topics: Aminoquinolines; Animals; Antimalarials; Cell Line, Tumor; Chemistry Techniques, Synthetic; Chloroquine; Cost-Benefit Analysis; Drug Resistance; L-Lactate Dehydrogenase; Male; Mice; Molecular Docking Simulation; Plasmodium falciparum; Plasmodium vivax; Structure-Activity Relationship | 2016 |
Incorporation of an intramolecular hydrogen bonding motif in the side chain of antimalarial benzimidazoles.
Topics: | 2019 |
Hybridization of Fluoro-amodiaquine (FAQ) with Pyrimidines: Synthesis and Antimalarial Efficacy of FAQ-Pyrimidines.
Topics: | 2019 |
Novel Antimalarial Tetrazoles and Amides Active against the Hemoglobin Degradation Pathway in
Topics: Amides; Antimalarials; Drug Resistance, Microbial; Hemeproteins; Hemoglobins; Hep G2 Cells; Humans; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Small Molecule Libraries; Structure-Activity Relationship; Tetrazoles | 2021 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |